I joined pharmaceutical development in 2003 as line manager in analytical science working primarily in late phase projects. After secondments to formulated product development and then post approval regulatory, I returned to drug substance in 2014 as a principle scientist responsible for promoting control strategy and measurement science. My current focus is the development of tools to help project teams visualise control strategies earlier, prior to phase III and across substance and product.